Hemodialysis patient who develops multiple myeloma, treated with autotransplantation of bone marrow

  • Fernando Segovia División Nefrología, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires
  • Sandra Marlene Ríos Medio Interno, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires
  • Yeison Rubén Pérez Ibarra Medio Interno, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires
  • Rodolfo Vavich División Nefrología, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires
  • Alicia Marini División Nefrología, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires
Keywords: hemodialysis, renal dialysis, bone marrow transplantation, multiple myeloma

References

Attal M, Moreau P, Avet-Loiseau H, Harousseau JL. Stem cell transplantation in multiple myeloma. Hematology Am Soc Hematol Educ Program. 2007:311-6.

Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M, et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol. 2001;114(4):822-9.

Dimopoulos MA, Terpos E. Renal insufficiency and failure. Hematology Am Soc Hematol Educ Program. 2010;2010:431-6.

Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010;28(33):4976-84.

Imrie K, Rumble RB, Crump M. Stem cell transplantation in adults. Recommendation Report [Internet]. Cancer Care Ontario Program in Evidence-based Care, 2009. 79 p. Disponible en: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=35448 [Consulta sept. 2013]

Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation. 2011;91(6):672-6.

Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, De Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant. 2010;25(4):1200-6.

Published
2017-08-18
How to Cite
1.
Segovia F, Ríos SM, Pérez Ibarra YR, Vavich R, Marini A. Hemodialysis patient who develops multiple myeloma, treated with autotransplantation of bone marrow. Rev Nefrol Dial Traspl. [Internet]. 2017Aug.18 [cited 2024Dec.23];33(3):167-73. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/161
Section
Case Report